Winthrop Partners WNY LLC Buys New Holdings in Procter & Gamble Company (The) $PG

Winthrop Partners WNY LLC purchased a new position in Procter & Gamble Company (The) (NYSE:PGFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 7,426 shares of the company’s stock, valued at approximately $1,064,000.

Other large investors also recently modified their holdings of the company. Carson Advisory Inc. increased its holdings in Procter & Gamble by 0.5% in the fourth quarter. Carson Advisory Inc. now owns 12,124 shares of the company’s stock valued at $1,738,000 after buying an additional 65 shares during the last quarter. Trilogy Capital Inc. increased its position in Procter & Gamble by 1.1% during the fourth quarter. Trilogy Capital Inc. now owns 6,289 shares of the company’s stock worth $901,000 after buying an additional 67 shares during the period. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Procter & Gamble by 1.8% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 3,829 shares of the company’s stock valued at $549,000 after acquiring an additional 67 shares during the period. Lorne Steinberg Wealth Management Inc. increased its stake in Procter & Gamble by 2.7% in the fourth quarter. Lorne Steinberg Wealth Management Inc. now owns 2,623 shares of the company’s stock valued at $376,000 after purchasing an additional 68 shares during the period. Finally, Grant Street Asset Management Inc. increased its position in Procter & Gamble by 2.7% in the 4th quarter. Grant Street Asset Management Inc. now owns 2,627 shares of the company’s stock valued at $376,000 after acquiring an additional 69 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Trading Up 0.3%

Shares of PG stock opened at $150.85 on Friday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The stock has a market cap of $351.26 billion, a P/E ratio of 22.05, a P/E/G ratio of 6.54 and a beta of 0.39. The business has a fifty day simple moving average of $145.43 and a 200-day simple moving average of $147.80. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, April 24th. The company reported $1.59 EPS for the quarter, topping the consensus estimate of $1.56 by $0.03. The business had revenue of $21.23 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Friday, April 24th were issued a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend was Friday, April 24th. Procter & Gamble’s payout ratio is currently 63.60%.

Analyst Upgrades and Downgrades

PG has been the topic of several recent research reports. JPMorgan Chase & Co. dropped their price objective on shares of Procter & Gamble from $165.00 to $162.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Sanford C. Bernstein began coverage on Procter & Gamble in a report on Thursday, June 11th. They issued a “market perform” rating and a $156.00 price objective on the stock. UBS Group boosted their target price on Procter & Gamble from $166.00 to $172.00 and gave the stock a “buy” rating in a research report on Monday, April 27th. Royal Bank Of Canada cut their target price on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating for the company in a research note on Thursday, April 9th. Finally, TD Cowen raised their price target on Procter & Gamble from $142.00 to $150.00 and gave the company a “hold” rating in a report on Monday, April 27th. Eleven equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $160.78.

Get Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.